CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test
Introduction
The CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test is a vital diagnostic tool designed to identify genetic mutations associated with multiple endocrine neoplasia type 1 (MEN1) syndrome. This condition increases the risk of developing various cancers, particularly those affecting the endocrine glands. Understanding your genetic predisposition through this test is crucial for early detection and intervention.
What the Test Measures
This genetic test specifically analyzes the CDKN2B gene using next-generation sequencing (NGS) technology. It detects mutations that may lead to MEN1 syndrome, allowing healthcare providers to assess an individual’s risk of developing related cancers.
Who Should Consider This Test?
Individuals with a family history of MEN1 syndrome or those showing symptoms such as:
- Hyperparathyroidism
- Pancreatic endocrine tumors
- Pituitary tumors
- Adrenal tumors
are encouraged to consider this test. Additionally, individuals identified as high-risk due to genetic counseling should also seek this test.
Benefits of Taking the Test
- Early detection of genetic predisposition to cancer.
- Informed decision-making regarding health management.
- Guidance for family members who may also be at risk.
- Access to preventive measures and treatment options.
Understanding Your Results
Results from the CDKN2B gene test will indicate whether mutations are present. A positive result may suggest a higher risk of developing MEN1-related cancers, while a negative result can provide reassurance. It is essential to discuss your results with a healthcare professional for proper interpretation and advice on next steps.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
Don’t wait for symptoms to appear. Take control of your health by booking the CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test today. Call or WhatsApp us at +2348077798758 to schedule your appointment.
Turnaround time for results is approximately 3 to 4 weeks. Please ensure you provide a clinical history and attend a genetic counseling session prior to testing, where a pedigree chart will be drawn to assess family history related to the CDKN2B gene.
Sample type required: Blood or Extracted DNA or One drop Blood on FTA Card.
Consult with an oncologist or genetic specialist to understand how this test can benefit your health.
